secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2023-06-23T23:59:59+00:00
Accession:  0001213900-23-051421
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Allarity Therapeutics stockholders approve reverse stock split of up to 1-for-50
--------------------------------------------------------------------------------

- Shareholders approved reverse stock split at ratio between 1-for-15 and 1-for-50, ratio set by Board with Series A consent.
- Reverse stock split proposal received 24,984,901 votes for, 7,906,612 against, and 40,629 abstentions.
- Adjournment proposal approved with 27,928,931 votes for, 4,899,237 against, and 103,974 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023051421/0001213900-23-051421-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390023051421/ea180879-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-051421

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer